Marisa Ninivaggi
Marisa Ninivaggi publishes mostly in Hematology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine, on topics such as Blood Coagulation and Thrombosis Mechanisms, Platelet Disorders and Treatments and Venous Thromboembolism Diagnosis and Management.
- World rank
- #2,002,519 of 7,710,434 ranked researchers
- Rank in Netherlands
- #43,555 of 107,149
- Works
- 64
- Citations
- 1.1k
- Citations per work
- 17.2
What does Marisa Ninivaggi research?
Marisa Ninivaggi's work is mostly in Medicine (60%), Biochemistry, Genetics and Molecular Biology (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3960.2%
- Medicine3960.2%
- Everything else2234.7%
- Life Sciences35.1%
- 1Hematology32% of their works
- 2Cardiology and Cardiovascular Medicine10% of their works
- 3Pulmonary and Respiratory Medicine7% of their works
- 4Internal Medicine6% of their works
- 5Genetics5% of their works
- 6Rheumatology5% of their works
Research topics
- Blood Coagulation and Thrombosis Mechanisms
- Platelet Disorders and Treatments
- Venous Thromboembolism Diagnosis and Management
- Atrial Fibrillation Management and Outcomes
- Hemophilia Treatment and Research
- Blood properties and coagulation
- Systemic Lupus Erythematosus Research
- Heparin-Induced Thrombocytopenia and Thrombosis
Which keywords describe Marisa Ninivaggi's research?
The keywords of their largest research topics: Hemostasis, Inflammation, Antithrombotic Therapy, Protease-Activated Receptors, Thrombin, Prophylaxis, Thrombosis and Diagnosis.
- Vaccination
- Systemic Lupus Erythematosus
- Transglutaminases
- Fibrinogen
- Atrial Fibrillation
- Venous Thromboembolism
- Platelets
- Diagnosis
- Prophylaxis
- Protease-Activated Receptors
- Inflammation
- Hemostasis
- Antithrombotic Therapy
- Thrombin
- Thrombosis
- Immune Thrombocytopenic Purpura
- Pulmonary Embolism
- Anticoagulant Therapy
- Factor VIII
- Hemophilia
- Antiphospholipid Syndrome
- Heparin-Induced Thrombocytopenia
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Hemostasis503 topics
- Inflammation402 topics
- Antithrombotic Therapy392 topics
- Protease-Activated Receptors281 topic
- Thrombin281 topic
- Prophylaxis212 topics
- Thrombosis192 topics
- Diagnosis182 topics
- Immune Thrombocytopenic Purpura121 topic
- Platelets121 topic
- Pulmonary Embolism111 topic
- Venous Thromboembolism111 topic
- Anticoagulant Therapy101 topic
- Atrial Fibrillation101 topic
- Factor VIII101 topic
- Fibrinogen101 topic
- Hemophilia101 topic
- Transglutaminases101 topic
- Antiphospholipid Syndrome91 topic
- Systemic Lupus Erythematosus91 topic
- Heparin-Induced Thrombocytopenia71 topic
- Vaccination71 topic
Where does Marisa Ninivaggi work?
Marisa Ninivaggi's main affiliation in the publication record is Synapse (Netherlands), Netherlands.
How many publications and citations does Marisa Ninivaggi have?
OpenAlex counts 64 works and 1,103 citations for Marisa Ninivaggi, an h-index of 19, ranking #2,002,519 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Marisa Ninivaggi. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.